1. Takamatsu Y, Imai M, Maeda K, Nakajima N, Higashi-Kuwata N, Iwatsuki-Horimoto K, Ito M, Kiso M, Maemura T, Takeda Y, Omata K, Suzuki T, Kawaoka Y, Mitsuya H. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. J Virol. 2022, 96(4):e0155121. doi: 10.1128/JVI.01551-21
2. Maeda K, Amano M, Uemura Y, Tsuchiya K, Matsushima T, Noda K, Shimizu Y, Fujiwara A, Takamatsu Y, Ichikawa Y, Nishimura H, Kinoshita M, Matsumoto S, Gatanaga H, Yoshimura K, Oka SI, Mikami A, Sugiura W, Sato T, Yoshida T, Shimada S, Mitsuya H. Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals. Sci Rep. 2021, 11(1):22848. doi: 10.1038/s41598-021-01930-y
3. Terada M, Kutsuna S, Togano T, Saito S, Kinoshita N, Shimanishi Y, Suzuki T, Miyazato Y, Inada M, Nakamoto T, Nomoto H, Ide S, Sato M, Maeda K, Matsunaga A, Satake M, Matsubayashi K, Tsuno H, Kojima M, Kuramistu M, Tezuka K, Ikebe E, Okuma K, Hamaguchi I, Shiratori K, Sato M, Kawakami Y, Inaba K, Igarashi S, Yamauchi R, Matsumura M, Ishimaru K, Zhang B, Kuge C, Ishihara M, Gouda M, Tanaka K, Ishizaka Y, Ohmagari N. How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021, 61(7):1998-2007. doi: 10.1111/trf.16541
4. Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Maeda K, Takasaki J, Hojo M, shizaka Y, Ohmagari N. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother., 2021, 27(6):808-813. doi: 10.1016/j.jiac.2021.01.006
5. Suzuki T, Asai Y, Ide S, Fukuda S, Tanaka A, Shimanishi Y, Takahashi K, Terada M, Sato L, Sato M, Inada M, Yamada G, Miyazato Y, Akiyama Y, Nomoto H, Nakamoto T, Nakamura K, Togano T, Morioka S, Kinoshita-Iwamoto N, Saito S, Kutsuna S, Ohmagari N. Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan. J Infect Chemother. 2022 Feb;28(2):206-210. doi: 10.1016/j.jiac.2021.10.012. Epub 2021 Oct 20. PMID: 34756573; PMCID: PMC8526427
6. Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ J. 2021 May 25;85(6):944-947. doi: 10.1253/circj.CJ-21-0219. Epub 2021 May 15. PMID: 33994409
7. Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K, Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N. Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 Jun;107:255-256. doi: 10.1016/j.ijid.2021.04.088. Epub 2021 May 4. PMID: 33962081
8. Nomoto H, Kutsuna S, Okuma K, Kuramitsu M, Tezuka K, Ikebe E, Saito S, Kinoshita N, Terada M, Endo M, Suzuki T, Miyazato Y, Nakamoto T, Inada M, Hamaguchi I, Ohmagari N. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr;27(4):653-655. doi: 10.1016/j.jiac.2021.01.004. Epub 2021 Jan 15. PMID: 33487533; PMCID: PMC7836836
9. Yusuke Miyazato, Shinya Tsuzuki, Shinichiro Morioka, Mari Terda, Satoshi Kutsuna, Sho Saito, Yumiko Shimanishi, Kozue Takahashi, Mio Sanada, Masako Akashi, Chika Kuge, Yasuyo Osanai, Keiko Tanaka, Michiyo Suzuki, Kayoko Hayakawa, Norio Ohmagari. Risk factors associated with development and persistence of long COVID medRxiv 2021.09.22.21263998; doi: https://doi.org/10.1101/2021.09.22.21263998